Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress

Applied Skills Session 2501

Troubleshooting Parkinson's Disease: Infusion Therapies in the Clinic

Monday, October 5, 2026
16:00 - 17:30 | Conference Room North 201, Level 2

In this session, the faculty will use case-based discussions to demonstrate key considerations for patient selection for infusion therapies, factors influencing selection of Levodopa-carbidopa intestinal gel (LCIG) / Levodopa-entacapone-carbidopa intestinal gel (LECIG) or subcutaneous preparations and setting patient and clinician expectations. Participants will learn to recognize the clinical scenarios where escalation to infusion therapies may be appropriate.

Moderator(s):

Laura Williams, Ireland

Presenters:

Sarah Bray, Australia

Valentina Leta, Italy

CSPC Liaison(s):

Laura Williams, Ireland

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Recognize indications for initiation and selection of infusion therapies in people with Parkinson’s disease
  2. Apply infusion therapies for the management of motor and non-motor fluctuations in Parkinson’s disease
  3. Screen for, assess, and manage emergent complications of infusion therapies

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)

Education Level

Beginner / Foundational
Intermediate / Experienced